NovaBay Pharmaceuticals (NBY) Posts Q1 Loss of 8c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq futures slide as Alphabet results intensify AI spending fears
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $1.95 --0%
Financial Fact:
Provision for income taxes: 0
Today's EPS Names:
ITGR, CARE, CCB, More
Financial Fact:
Provision for income taxes: 0
Today's EPS Names:
ITGR, CARE, CCB, More
Join SI Premium – FREE
NovaBay Pharmaceuticals (NYSE: NBY) reported Q1 EPS of ($0.08), $0.03 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $188 thousand versus the consensus estimate of $490 thousand.
For earnings history and earnings-related data on NovaBay Pharmaceuticals (NBY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- InterDigital (IDCC) Tops Q3 EPS by 177c ; Offers Guidance
- Marvell shares sink as Alphabet miss and Lumentum deal reports weigh on sentiment
- Radico Khaitan Ltd (RDCK:IN) PT Raised to INR4,729 at Investec
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
